First Participant Enrolled in Second Cohort of BiondVax's Pivotal, Clinical Efficacy, Phase 3 Universal Flu Vaccine Trial
Stock Information for Scinai Immunotherapeutics Ltd Sponsed ADR (New)
Loading
Please wait while we load your information from QuoteMedia.